HHS and Regeneron to develop therapeutics for influenza and emerging pathogens

The US Department of Health and Human Services ’ Office of the Assistant Secretary for Preparedness and Response (ASPR) has partnered with Regeneron Pharmaceuticals to develop new therapeutics to treat influenza and emerging infectious diseases.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news